Dr. Marc J. Kahn

Request as Speaker

Request as Media Expert

Chief of Hematology, Department of Internal Medicine

Expertise: Medicine, Hematology, Oncology, Health education, Business of medicine

Biography

Dr. Marc J. Kahn is chief of hematology at the Kirk Kerkorian School of Medicine's Department of Internal Medicine. He is a prolific researcher in benign hematology, medical education, and healthcare finance.

He has served in leadership roles with the Association of American Medical Colleges, American College of Physicians, American Society of Hematology, National Board of Medical Examiners, and the National Residency Matching Program.

Dr. Kahn has authored over 100 peer-reviewed manuscripts in addition to 110 book chapters and five textbooks. In 2020, his most recent textbook, “Business Basics of Building and Managing a Healthcare Practice,” was published by Springer Nature.

He formerly served as vice president for health affairs at UNLV and as dean of the university's medical school — developing curricula, clinical programs, and research to elevate healthcare in the region. Prior to joining UNLV in April 2020, Dr. Kahn was a senior associate dean at Tulane University School of Medicine.

Education

M.D., University of Pennsylvania School of Medicine
M.B.A., Tulane University
B.A., Chemistry, University of Pennsylvania

Search For Other Experts On

health & medicine

Dr. Marc J. Kahn In The News

New pancreatic cancer drug offers hope but raises access questions with a hefty price tag

A newly approved pancreatic cancer drug is offering new hope for some patients, but its nearly half-million-dollar price tag is raising questions about who will be able to access it and how families might afford it.

UNLV Doctor Explains CTE Risks, Symptoms Ahead of Raiders-49ers Matchup

As the Las Vegas Raiders prepare to face the San Francisco 49ers, brain health remains an important topic in football.

UNLV doctor applauds future of treatment as melanoma vaccine succeeds in large trial

One UNLV doctor and professor is applauding the breakthrough results as a personalized mRNA cancer vaccine has shown promise for preventing recurrence of melanoma, according to a new trial from drugmakers Merck and Moderna.

Henderson Hospital to close NICU and maternity services around Sept. 30

A neonatal intensive care unit that serves some of the region’s most vulnerable newborns is set to close in Henderson, reducing the number of NICUs available in Clark County.